- Home
- IFRX vs FSI Comparison
IFRX vs FSI Comparison
Compare IFRX & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- FSI
- Stock Information
- Founded
- IFRX 2007
- FSI 1991
- Country
- IFRX Germany
- FSI Canada
- Employees
- IFRX N/A
- FSI N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- FSI Recreational Games/Products/Toys
- Sector
- IFRX Health Care
- FSI Consumer Discretionary
- Exchange
- IFRX Nasdaq
- FSI Nasdaq
- Market Cap
- IFRX 53.5M
- FSI 55.6M
- IPO Year
- IFRX 2017
- FSI 1999
- Fundamental
- Price
- IFRX $0.87
- FSI $5.49
- Analyst Decision
- IFRX Strong Buy
- FSI
- Analyst Count
- IFRX 4
- FSI 0
- Target Price
- IFRX $7.75
- FSI N/A
- AVG Volume (30 Days)
- IFRX 359.0K
- FSI 27.6K
- Earning Date
- IFRX 08-07-2025
- FSI 08-13-2025
- Dividend Yield
- IFRX N/A
- FSI 1.84%
- EPS Growth
- IFRX N/A
- FSI N/A
- EPS
- IFRX N/A
- FSI 0.18
- Revenue
- IFRX $140,242.00
- FSI $36,483,680.00
- Revenue This Year
- IFRX N/A
- FSI $21.91
- Revenue Next Year
- IFRX $1,276.37
- FSI $42.35
- P/E Ratio
- IFRX N/A
- FSI $29.88
- Revenue Growth
- IFRX 30.90
- FSI N/A
- 52 Week Low
- IFRX $0.71
- FSI $1.65
- 52 Week High
- IFRX $2.82
- FSI $7.24
- Technical
- Relative Strength Index (RSI)
- IFRX 45.31
- FSI 55.04
- Support Level
- IFRX $0.82
- FSI $5.13
- Resistance Level
- IFRX $0.93
- FSI $5.93
- Average True Range (ATR)
- IFRX 0.06
- FSI 0.30
- MACD
- IFRX 0.02
- FSI -0.02
- Stochastic Oscillator
- IFRX 33.94
- FSI 44.74
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.